Cencora, Inc. (COR)
NYSE: COR · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Conshohocken, PA · filing with the SEC since 2001
Grade5.8
◀ Past 6.5● Present 6.2▶ Future 4.8
Who owns Cencora, Inc.
As filed with the SECHolders of 5% or more
2
Blackrock, Inc. holds 8.5% of Common Stock, as its SCHEDULE 13G/A filed Jan 31, 2025 says.
Directors and officers
19
report now, of 36 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Jan 31, 2025 · Common Stock
Vanguard Capital Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
Walgreens Boots Alliance Holdings LLC
SCHEDULE 13D/A · filed Jun 9, 2025 · Common Stock, par value $0.01 per share · reported falling below 5%, from 5.4% in May 28, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 11.6% in Jul 29, 2025
What COR reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Retina Consultants of America (RCA)
A company bought · acquisition · Dec 2024 · owns, named in the 10-K filed Nov 25, 2025
One Oncology
A company bought · acquisition · Jun 2023 · owns, named in the 10-K filed Nov 25, 2025
PharmaLex Holding Gmbh (PharmaLex)
A company bought · acquisition · Dec 2022 · owns, named in the 10-K filed Nov 25, 2025
21 subsidiaries in 7 countries, from the list filed with the 10-K filed Nov 25, 2025.
Insider tradesForm 4
13sales
3purchases
8sales on a scheduled plan
5people selling
$15.4Msold, in dollars
$2.3Mbought, in dollars
Open-market trades on Form 4 from Nov 10, 2025 to Nov 10, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 10, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window7 of 39 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Mauch Robert P. | President & CEO | 5 | $7.3M | 5 | 0 | $0 |
| Campbell Elizabeth S | Executive Vice President | 2 | $4.8M | 0 | 0 | $0 |
| Krikorian Lazarus | SVP & Chief Accounting Officer | 4 | $2.3M | 3 | 0 | $0 |
| Battaglia Silvana | Executive Vice President | 1 | $600,000 | 0 | 0 | $0 |
| Greenberg Lon R | director | 1 | $400,000 | 0 | 0 | $0 |
| Durcan Dermot Mark | director | 0 | $0 | 0 | 2 | $2.2M |
| Tyler Lauren M | director | 0 | $0 | 0 | 1 | $100,000 |